Literature DB >> 27579759

Syndrome in question: Gorlin-Goltz syndrome.

Pauline Lyrio Ribeiro1, João Basílio de Souza1, Karina Demoner de Abreu1, Marisa Simon Brezinscki1, Christine Chambo Pignaton1.   

Abstract

The Nevoid Basal Cell Carcinoma Syndrome (NBCCS) is an uncommon disorder caused by a mutation in Patched, tumor suppressor gene. It is mainly characterized by numerous early onset basal cell carcinomas, odontogenic cysts of jaw and skeletal abnormalities. Due to the wide clinical spectrum, treatment and management of its modalities are not standardized and should be individualized and monitored by a multidisciplinary team. We report a typical case in a 30-year-old man with multiple basal cell carcinomas, keratotic pits of palmar creases and bifid ribs, with a history of several corrective surgeries for keratocystic odontogenic tumors, among other lesions characteristic of the syndrome.

Entities:  

Mesh:

Year:  2016        PMID: 27579759      PMCID: PMC4999122          DOI: 10.1590/abd1806-4841.20164428

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  9 in total

1.  Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome.

Authors:  R J GORLIN; R W GOLTZ
Journal:  N Engl J Med       Date:  1960-05-05       Impact factor: 91.245

Review 2.  Nevoid basal cell carcinoma (Gorlin) syndrome.

Authors:  Robert J Gorlin
Journal:  Genet Med       Date:  2004 Nov-Dec       Impact factor: 8.822

Review 3.  Skin cancer chemoprevention with systemic retinoids: an adjunct in the management of selected high-risk patients.

Authors:  Ross M Campbell; John J DiGiovanna
Journal:  Dermatol Ther       Date:  2006 Sep-Oct       Impact factor: 2.851

Review 4.  Nevoid basal cell carcinoma syndrome: review of 118 affected individuals.

Authors:  S Shanley; J Ratcliffe; A Hockey; E Haan; C Oley; D Ravine; N Martin; C Wicking; G Chenevix-Trench
Journal:  Am J Med Genet       Date:  1994-04-15

Review 5.  Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome.

Authors:  V E Kimonis; A M Goldstein; B Pastakia; M L Yang; R Kase; J J DiGiovanna; A E Bale; S J Bale
Journal:  Am J Med Genet       Date:  1997-03-31

6.  Nevoid basal cell carcinoma syndrome. Clinical findings in 37 Italian affected individuals.

Authors:  L Lo Muzio; P F Nocini; A Savoia; U Consolo; M Procaccini; L Zelante; G Pannone; P Bucci; M Dolci; F Bambini; P Solda; G Favia
Journal:  Clin Genet       Date:  1999-01       Impact factor: 4.438

7.  Complications of the naevoid basal cell carcinoma syndrome: results of a population based study.

Authors:  D G Evans; E J Ladusans; S Rimmer; L D Burnell; N Thakker; P A Farndon
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

Review 8.  Nevoid basal cell carcinoma syndrome: a review of the literature.

Authors:  M Manfredi; P Vescovi; M Bonanini; S Porter
Journal:  Int J Oral Maxillofac Surg       Date:  2004-03       Impact factor: 2.789

9.  Gorlin-Goltz syndrome: clinicopathologic aspects.

Authors:  Aitziber Ortega García de Amezaga; Olatz García Arregui; Sergio Zepeda Nuño; Amelia Acha Sagredo; José M Aguirre Urizar
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2008-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.